Skip to main content
Caplight Logo









DigiFluidic Bio-Technology

DigiFluidic Bio-Technology

Private
SingaporeHealthcare & Life Scienceshttps://digifluidic.com/

Last Round

Series A

Extension

Sep 29, 2022

Total Funding Raised

$15.45M

Company Overview

DigiFluidic Bio-Technology is a biotechnology company that develops a fully automated, programmable digital fluidic platform for a wide range of life science applications.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

digital microfluidicsnucleic acid analysispoint-of-care testingPOCTlab-on-a-chiprapid diagnosticsmolecular diagnosticsmicrofluidic chipsportable diagnosticsin vitro diagnosticsbiotech equipmentfood safety testinganimal disease detectionrazor and blade modelODM/OEM services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DigiFluidic Bio-Technology Comparables

Compare DigiFluidic Bio-Technology with similar companies based on industry and business-model similarity.

DigiFluidic Bio-Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prompt Diagnostics
81%
FluxErgy
79%
Genetic Microdevices Limited
78%

DigiFluidic Bio-Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionSep 29, 2022

DigiFluidic Bio-Technology Investors

Notable investors and investment history

DigiFluidic Bio-Technology investors
InvestorRounds
ConvergenceSeries A Extension
Guangzhou Huiju Capital Equity Investment Management Co., Ltd.Series A Extension
Guangzhou Qudao Asset ManagementSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 40% MoM.

  • Apr 1, 2026

    Monthly visitors increased 56% MoM, reaching 1.4K.

DigiFluidic Bio-Technology Filings

Explore SEC and related filing metadata, where available.

DigiFluidic Bio-Technology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DigiFluidic Bio-Technology's valuation, stock price, and market status.

Is DigiFluidic Bio-Technology a public or private company?

DigiFluidic Bio-Technology is a private company.

What is the current stock price of DigiFluidic Bio-Technology?

DigiFluidic Bio-Technology is a private company with no public stock price. No recent secondary market data is available.

How much is DigiFluidic Bio-Technology worth (valuation)?

Valuation information for DigiFluidic Bio-Technology is not publicly available.

Can I buy DigiFluidic Bio-Technology stock?

DigiFluidic Bio-Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DigiFluidic Bio-Technology's last funding round?

DigiFluidic Bio-Technology's most recent funding round was Series A Extension on September 29, 2022.

Who are the main investors in DigiFluidic Bio-Technology?

Key investors in DigiFluidic Bio-Technology include Guangzhou Qudao Asset Management.

Will DigiFluidic Bio-Technology IPO soon?

No public IPO plans have been announced for DigiFluidic Bio-Technology.

How can I track DigiFluidic Bio-Technology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DigiFluidic Bio-Technology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range2
Year Founded2021
Last FundingSep 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?